Kintai Therapeutics
Manufacturing · Virginia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4445 Corporation Ln Ste 259, Virginia Be...Phone Number
(617) 409-7395Website
www.kintaitx.comRevenue
$6 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Kintai Therapeutics
Kintai Therapeutics is a developer of healthcare technology platform designed to leverage the body's robust signaling networks based on orally available small molecule therapeutics to restore health and fight disease. The company's products are created using AI-based algorithms, enabling the researchers to use Enteric Biology and Analytics and Precision Enteric Medicines (PEM) Discovery Platform to discover disease.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kintai Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Kintai Therapeutics has new funding data
Kintai Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Kintai Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Kintai Therapeutics
Product Launch: Get notified when Kintai Therapeutics launches new products
Check out if Kintai Therapeutics is spiking on competitors!
Check if Kintai Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Kintai Therapeutics recently announced quarterly report
Recommended Actions
Find VP level buyers at Kintai Therapeutics
Find more new buyers
Compare Similar Companies to Kintai Therapeutics
Compare insights from companies similar to Kintai Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Kintai Therapeutics
$6M
11-50
Private
-
2016
N/A
Company Profile Activity
Activity Insights
Kintai Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Kintai Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Kintai Therapeutics.
Kintai Therapeutics Tech Stack
A closer look at the technologies used by Kintai Therapeutics
Kintai Therapeutics News & Media
Kintai Therapeutics Advances Anti-Obesity Agent KTX-0200 into IND-Enabling Studies Following Positive Preclinical Data Demonstrating Sustained Weight Loss and Improved Health Markers
CAMBRIDGE, Mass., Jan. 22, 2020 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a Flagship Pioneering company, today announced the advancement of KTX-0200, a novel oral anti-obesity agent, into IND-enabling studies following the demonstration of sustained weight loss and improved markers of health in preclinical studies. Treatment with KTX-0200 led to sustained weight loss of 14% in chronic diet-induced obesity rodent models known to be predictive of clinical efficacy across anti-obesity drug mechanismKintai Therapeutics Appoints Biotech Veteran John Mendlein, Ph.D., as Chairman of the Board of Directors
CAMBRIDGE, Mass., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a Flagship Pioneering company, today announced the appointment of biotech industry veteran John Mendlein, Ph.D., to its Board of Directors as chairman of the board. Dr. Mendlein, who currently serves as executive partner at Flagship Pioneering, brings over 23 years of biotech industry expertise to Kintai. Dr. Mendlein replaces Jim Gilbert, who has transitioned off of the board.Kintai Therapeutics Appoints Biotech Veteran John Mendlein, Ph.D., as Chairman of the Board of ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.Kintai Therapeutics Announces the Appointment of Dr. Francesca Barone as Head of Experimental Medicine
CAMBRIDGE, Mass., Oct. 21, 2019 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a Flagship Pioneering company, today announced that Francesca Barone, M.D., Ph.D., has joined Kintai as the head of experimental medicine.
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kintai Therapeutics
Sign Up For FreeTo access detailed company insights
Kintai Therapeutics is a developer of healthcare technology platform designed to leverage the body's robust signaling networks based on orally available small molecule therapeutics to restore health and fight disease. The company's products are created using AI-based algorithms, enabling the researchers to use Enteric Biology and Analytics and Prec... Read More
